Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.

Bostom, A G; Shemin, D; Bagley, P; Massy, Z A; Zanabli, A; Christopher, K; Spiegel, P; Jacques, P F; Dworkin, L; Selhub, J

Bostom, A G; Shemin, D; Bagley, P; Massy, Z A; Zanabli, A; Christopher, K; Spiegel, P; Jacques, P F; Dworkin, L; Selhub, J.

Affiliation

Bostom AG; Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA. abostom@loa.com

Circulation ; 101(24): 2829-32, 2000 Jun 20.

Article de En | MEDLINE | ID: mdl-10859289

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tétrahydrofolates / Dialyse rénale / Hyperhomocystéinémie / Acide folique Type d'étude: Clinical_trials Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Circulation Année: 2000 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links